CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on cancer drug development by targeting the epigenetic mechanisms that control gene expression in tumors. It aims to develop novel compounds targeting the BRD9 protein, with the goal of translating these findings into effective cancer treatments.
Cancer can be considered a disease of gene control; since dysregulated patterns of gene expression are a feature of all tumours.
Excitingly, targeting the underlying epigenetic mechanisms that promote oncogenic gene expression in cancer cells is providing significant opportunities for cancer drug development.
Indeed, initial successes in this area may soon be leveraged for the benefit of cancer patients.
Expanding European research capabilities in this area is essential, since approximately 1.5…
THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
